Henry WA, Gordin JM, Ware JHEchocardiographic measurements in normal subjects from infancy to old age . Circulation1980;62:1054-61.
3.
Kirkendall WM , Feinleib M., Freis ED, et al. Recommendations for human blood pressure determination by sphygmomanometers. Circulation1980;62: 1146A-55A.
4.
Elseed AM, Shinebourne EA, Joseph MCAssessment of techniques for measurement of blood pressure in infants and children. Arch Dis Child1973;48: 932-6.
5.
de Swiet M., Fayers P., Shinebourne EASystolic blood pressure in a population of infants in the first year of life: the Brompton Study. Pediatrics1980 ;65:1028-35.
6.
Keith JD, Rose V., Manning JA, Endocardial fibroelastosis. In: Keith JD, Rowe RD, Vlad P, eds. Heart disease in infancy and childhood. 3rd ed. New York: Macmillan , 1978:941-57.
7.
Edwin C., Lanes R., Migeon CJ, et al. Persistence of the enzymatic block in adolescent patients with salt-losing congenital adrenal hyperplasia. J Pediatr1979;95:534-7.
8.
Monteleone JAHypertensive encephalopathy with overdosage of deoxycorticosterone. Pediatrics1969;43:294-5.
9.
Marks JF, Fink CWProlonged hypertension following cessation of desoxycorticosterone therapy in congenital adrenal hyperplasia. Pediatrics1967;40: 184-7.
10.
Vazquez AM, Kenny FMHypertension secondary to excessive desoxycorticosterone implants or 9-alpha fluorocortisol in salt-losing congenital adrenal hyperplasia. J Pediatr1972:81:549-52.
11.
Kirkland JL , Kirkland RT, Librik L., et al. latrogenic hypertension in children with congenital adrenal hyperplasia. J Pediatr1973;83:687-9.